Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03580928 |
|---|---|
| Brief Title: | Acalabrutinib, Venetoclax, and Obinutuzumab for Initial Therapy of CLL (AVO) |
| First Submitted : | June 25, 2018 |
| First Submitted that Met QC Criteria : | July 6, 2018 |
| First Posted : | July 10, 2018 |
| Last Update Submitted that Met QC Criteria : | May 6, 2024 |
| Last Update Posted : | May 7, 2024 |